Skitsofrenian hoito (Finnish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Skitsofrenian hoito" in Finnish language version.

refsWebsite

Global rank Finnish rank

25nih.gov

4^th place

12^th place

24doi.org

2^nd place

10^th place

22worldcat.org

5^th place

9^th place

5web.archive.org

1^st place

4hs.fi

647^th place

3^rd place

2yle.fi

380^th place

2^nd place

2kaypahoito.fi

low place

233^rd place

1skitsofreniainfo.fi

low place

1e-mielenterveys.fi

low place

1theseus.fi

low place

157^th place

1kajak.fi

low place

4,313^th place

1julkari.fi

low place

566^th place

1nature.com

234^th place

201^st place

1terve.fi

low place

299^th place

1psychiatryonline.org

4,032^nd place

2,767^th place

1thelancet.com

2,393^rd place

1,029^th place

1oup.com

485^th place

642^nd place

1oulu.fi

low place

156^th place

1psu.edu

207^th place

1,082^nd place

1kvtietopankki.fi

low place

1amazon.co.uk

448^th place

1,329^th place

1sitruunakustannus.fi

low place

1jneurosci.org

low place

7,747^th place

1schres-journal.com

low place

amazon.co.uk

Whitaker, Robert: Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America. New York, NY: Broadway Books, 24.8.2011. ISBN 9780307452429 Teoksen verkkoversio Viitattu 21.12.2017 (englanniksi).

doi.org

dx.doi.org

Dorph-Petersen, Karl-Anton & Pierri, Joseph N & Perel, James M & Sun, Zhuoxin & Sampson, Allan R & Lewis, David A: The Influence of Chronic Exposure to Antipsychotic Medications on Brain Size before and after Tissue Fixation: A Comparison of Haloperidol and Olanzapine in Macaque Monkeys Neuropsychopharmacology. 18.1.2005. doi:doi:10.1038/sj.npp.1300710 Viitattu 29.03.2018.
Jari Tiihonen, Jari Haukka, Mark Taylor, Peter M. Haddad, Maxine X. Patel, Pasi Korhonen: A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. The American Journal of Psychiatry, June 2011, nro 6, s. 603–609. PubMed:21362741 doi:10.1176/appi.ajp.2011.10081224 ISSN 1535-7228 Artikkelin verkkoversio.
Peter Lepping, Rajvinder Singh Sambhi, Richard Whittington, Steven Lane, Rob Poole: Clinical relevance of findings in trials of antipsychotics: systematic review. The British Journal of Psychiatry: The Journal of Mental Science, 2011-05, nro 5, s. 341–345. PubMed:21525517 doi:10.1192/bjp.bp.109.075366 ISSN 1472-1465 Artikkelin verkkoversio.
Stefan Leucht, Claudia Leucht, Maximilian Huhn, Anna Chaimani, Dimitris Mavridis, Bartosz Helfer: Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors. American Journal of Psychiatry, 25.5.2017, nro 10, s. 927–942. doi:10.1176/appi.ajp.2017.16121358 ISSN 0002-953X Artikkelin verkkoversio.
Ni A. Khin, Yeh-Fong Chen, Yang Yang, Peiling Yang, Thomas P. Laughren: Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration. The Journal of Clinical Psychiatry, 2012-06, nro 6, s. 856–864. PubMed:22687813 doi:10.4088/JCP.11r07539 ISSN 1555-2101 Artikkelin verkkoversio.
Alexander M. Récalt, David Cohen: Withdrawal Confounding in Randomized Controlled Trials of Antipsychotic, Antidepressant, and Stimulant Drugs, 2000-2017. Psychotherapy and Psychosomatics, 2019, nro 2, s. 105–113. PubMed:30893683 doi:10.1159/000496734 ISSN 1423-0348 Artikkelin verkkoversio.
Stefan Leucht, Magdolna Tardy, Katja Komossa, Stephan Heres, Werner Kissling, Georgia Salanti: Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. The Lancet, 2.6.2012, nro 9831, s. 2063–2071. PubMed:22560607 doi:10.1016/S0140-6736(12)60239-6 ISSN 0140-6736 Artikkelin verkkoversio. (englanti)
P.B. Danborg, P.C. Gøtzsche: Benefits and harms of antipsychotic drugs in drug-naïve patients with psychosis: A systematic review. The International Journal of Risk & Safety in Medicine, Määritä ajankohta! PubMed:31561392 doi:10.3233/JRS-195063 ISSN 0924-6479 Artikkelin verkkoversio.
Tomi Bergström, Jyri J. Taskila, Birgitta Alakare, Päivi Köngäs-Saviaro, Jouko Miettunen, Jaakko Seikkula: Five-Year Cumulative Exposure to Antipsychotic Medication After First-Episode Psychosis and its Association With 19-Year Outcomes. Schizophrenia Bulletin Open, 1.1.2020, nro 1. doi:10.1093/schizbullopen/sgaa050 Artikkelin verkkoversio. (englanniksi)
Martin Harrow, Thomas H. Jobe, Liping Tong: Twenty-year effects of antipsychotics in schizophrenia and affective psychotic disorders. Psychological Medicine, 8.2.2021, s. 1–11. PubMed:33550993 doi:10.1017/S0033291720004778 ISSN 1469-8978 Artikkelin verkkoversio.
J. Moilanen, M. Haapea, J. Miettunen, E. Jääskeläinen, J. Veijola, M. Isohanni: Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication - a 10-year follow-up of the Northern Finland 1966 Birth Cohort study. European Psychiatry: The Journal of the Association of European Psychiatrists, 2013-01, nro 1, s. 53–58. PubMed:21920710 doi:10.1016/j.eurpsy.2011.06.009 ISSN 1778-3585 Artikkelin verkkoversio.
Roman Kotov, Laura Fochtmann, Kaiqiao Li, Marsha Tanenberg-Karant, Eduardo A. Constantino, Joan Rubinstein: Declining Clinical Course of Psychotic Disorders Over the Two Decades Following First Hospitalization: Evidence From the Suffolk County Mental Health Project. The American Journal of Psychiatry, 11 01, 2017, nro 11, s. 1064–1074. PubMed:28774193 doi:10.1176/appi.ajp.2017.16101191 ISSN 1535-7228 Artikkelin verkkoversio.
Anastasia Levinta, Ilya Mukovozov, Christopher Tsoutsoulas: Use of a Gluten-Free Diet in Schizophrenia: A Systematic Review. Advances in Nutrition (Bethesda, Md.), 11 01, 2018, nro 6, s. 824–832. PubMed:30325398 doi:10.1093/advances/nmy056 ISSN 2156-5376 Artikkelin verkkoversio.
Martin Harrow, Thomas H. Jobe: Does Long-Term Treatment of Schizophrenia With Antipsychotic Medications Facilitate Recovery? Schizophrenia Bulletin, syyskuu 2013, nro 5, s. 962–965. doi:10.1093/schbul/sbt034 ISSN 0586-7614 Artikkelin verkkoversio.
J. Moilanen & M. Haapea & J. Miettunen & E. Jääskeläinen & J. Veijola & M. Isohanni: Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication - a 10-year follow-up of the Northern Finland 1966 Birth Cohort study. European Psychiatry: The Journal of the Association of European Psychiatrists, tammikuu 2013, nro 1, s. 53–58. doi:10.1016/j.eurpsy.2011.06.009 ISSN 1778-3585 Artikkelin verkkoversio.
Wils, Regitze Sølling & Gotfredsen, Ditte Resendal & Hjorthøj, Carsten & Austin, Stephen F. & Albert, Nikolai & Secher, Rikke Gry: Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis. Schizophrenia Research, huhtikuu 2017, nro 182, s. 42–48. doi:10.1016/j.schres.2016.10.030 ISSN 1573-2509 Artikkelin verkkoversio.
Harrow, Martin & Jobe, Thomas H.: Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multifollow-up study. The Journal of Nervous and Mental Disease, toukokuu 2007, nro 5, s. 406–414. doi:10.1097/01.nmd.0000253783.32338.6e ISSN 0022-3018 Artikkelin verkkoversio.
Wunderink, Lex & Nieboer, Roeline M. & Wiersma, Durk & Sytema, Sjoerd & Nienhuis, Fokko J.: Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial. JAMA psychiatry, syyskuu 2013, nro 9, s. 913–920. doi:10.1001/jamapsychiatry.2013.19 ISSN 2168-6238 Artikkelin verkkoversio.
Seeman, Philip & Weinshenker, David & Quirion, Remi & Srivastava, Lalit K. & Bhardwaj, Sanjeev K. & Grandy, David K.: Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis. Proceedings of the National Academy of Sciences of the United States of America, 1.3.2005, nro 9, s. 3513–3518. doi:10.1073/pnas.0409766102 ISSN 0027-8424 Artikkelin verkkoversio.
Samaha, Anne-Noël & Seeman, Philip & Stewart, Jane & Rajabi, Heshmat & Kapur, Shitij: “Breakthrough” Dopamine Supersensitivity during Ongoing Antipsychotic Treatment Leads to Treatment Failure over Time. Journal of Neuroscience, 14.3.2007, nro 11, s. 2979–2986. doi:10.1523/JNEUROSCI.5416-06.2007 ISSN 0270-6474 (englanniksi) Artikkelin verkkoversio.
Dorph-Petersen, Karl-Anton & Pierri, Joseph N. & Perel, James M. & Sun, Zhuoxin & Sampson, Allan R. & Lewis, David A.: The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, syyskuu 2005, nro 9, s. 1649–1661. doi:10.1038/sj.npp.1300710 ISSN 0893-133X Artikkelin verkkoversio.
Anja P. Husa & Irina Rannikko & Jani Moilanen & Marianne Haapea & Graham K. Murray & Jennifer Barnett: Lifetime use of antipsychotic medication and its relation to change of verbal learning and memory in midlife schizophrenia — An observational 9-year follow-up study. Schizophrenia Research, 1.9.2014, nro 1, s. 134–141. doi:10.1016/j.schres.2014.06.035 ISSN 0920-9964 (englanniksi) Artikkelin verkkoversio.
Ho, Beng-Choon & Andreasen, Nancy C. & Nopoulos, Peg & Arndt, Stephan & Magnotta, Vincent & Flaum, Michael: Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Archives of General Psychiatry, kesäkuu 2003, nro 6, s. 585–594. doi:10.1001/archpsyc.60.6.585 ISSN 0003-990X Artikkelin verkkoversio.
Ho, Beng-Choon & Andreasen, Nancy C. & Ziebell, Steven & Pierson, Ronald & Magnotta, Vincent: Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Archives of General Psychiatry, helmikuu 2011, nro 2, s. 128–137. doi:10.1001/archgenpsychiatry.2010.199 ISSN 1538-3636 Artikkelin verkkoversio.

e-mielenterveys.fi

http://www.e-mielenterveys.fi/mielenterveyden-hairiot/psykoosi/ (Arkistoitu – Internet Archive)

hs.fi

Berner, Anna-Sofia: Torniossa mielenterveyshoito toimii Helsingin Sanomat. 16.12.2012. Viitattu 29.03.2018.
Berner, Anna-Sofia: Torniossa mielenterveyshoito toimii Helsingin Sanomat. 16.12.2012.
Tutkimus: Harhaäänet ovat länsimaissa ilkeämpiä kuin Intiassa ja Afrikassa HS.fi. Arkistoitu 13.3.2016. Viitattu 13.3.2016.
Berner, Anna-Sofia: Kovat keinot - Lepositeiden ja eristyksen käyttö vaihtelee paljon eri puolilla maata. Erot johtuvat asenteista Helsingin Sanomat, D1.. 22.8.2010.

jneurosci.org

Samaha, Anne-Noël & Seeman, Philip & Stewart, Jane & Rajabi, Heshmat & Kapur, Shitij: “Breakthrough” Dopamine Supersensitivity during Ongoing Antipsychotic Treatment Leads to Treatment Failure over Time. Journal of Neuroscience, 14.3.2007, nro 11, s. 2979–2986. doi:10.1523/JNEUROSCI.5416-06.2007 ISSN 0270-6474 (englanniksi) Artikkelin verkkoversio.

julkari.fi

Heilä, Hannele: Itsemurha skitsofreniaa sairastavien suurin vaaratekijä (s. 3) Kansan Terveys -lehti. joulukuu 10/1997. Viitattu 29.03.2018.

kajak.fi

gallia.kajak.fi

Ville Nissinen ja Antti Pikkarainen: Neuroleptit psykoosilääkkeinä. (Arkistoitu – Internet Archive) Kajaanin ammattikorkeakoulu.

kaypahoito.fi

Skitsofrenia – Käypä hoito -suositus 2020. Suomalainen Lääkäriseura Duodecim. Viitattu 17.5.2021.
Suositus - Käypä hoito - Skitsofrenia Käypä hoito. 22.01.2015. Viitattu 29.03.2018.

kvtietopankki.fi

KV-tietopankki – Skitsofrenia www.kvtietopankki.fi. Viitattu 3.3.2016.

nature.com

Dorph-Petersen, Karl-Anton & Pierri, Joseph N & Perel, James M & Sun, Zhuoxin & Sampson, Allan R & Lewis, David A: The Influence of Chronic Exposure to Antipsychotic Medications on Brain Size before and after Tissue Fixation: A Comparison of Haloperidol and Olanzapine in Macaque Monkeys Neuropsychopharmacology. 18.1.2005. doi:doi:10.1038/sj.npp.1300710 Viitattu 29.03.2018.

nih.gov

ncbi.nlm.nih.gov

Havaki-Kontaxaki, Beata J & Kontaxakis, Vassilis P & Margariti, Maria M & Paplos, Konstantinos G & Christodoulou, George N: Treatment of severe neuroleptic-induced tardive torticollis Annals of General Hospital Psychiatry. 17.10.2003. Viitattu 29.03.2018.
Jari Tiihonen, Jari Haukka, Mark Taylor, Peter M. Haddad, Maxine X. Patel, Pasi Korhonen: A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. The American Journal of Psychiatry, June 2011, nro 6, s. 603–609. PubMed:21362741 doi:10.1176/appi.ajp.2011.10081224 ISSN 1535-7228 Artikkelin verkkoversio.
National Center for Biotechnology Information, U. S. National Library of Medicine 8600 Rockville Pike, Bethesda MD, 20894 Usa: VALIDITY OF PSYCHIATRIC SYMPTOM SCALES AND CLINICAL IMPLICATIONS. Canadian Agency for Drugs and Technologies in Health, 2011/12. Teoksen verkkoversio Viitattu 6.3.2021. (englanniksi)
National Center for Biotechnology Information, U. S. National Library of Medicine 8600 Rockville Pike, Bethesda MD, 20894 Usa: VALIDITY OF PSYCHIATRIC SYMPTOM SCALES AND CLINICAL IMPLICATIONS. Canadian Agency for Drugs and Technologies in Health, 2011/12. Teoksen verkkoversio Viitattu 7.3.2021. (englanniksi)
P.B. Danborg, P.C. Gøtzsche: Benefits and harms of antipsychotic drugs in drug-naïve patients with psychosis: A systematic review. The International Journal of Risk & Safety in Medicine, Määritä ajankohta! PubMed:31561392 doi:10.3233/JRS-195063 ISSN 0924-6479 Artikkelin verkkoversio.
Martin Harrow, Thomas H. Jobe: Does Long-Term Treatment of Schizophrenia With Antipsychotic Medications Facilitate Recovery? Schizophrenia Bulletin, syyskuu 2013, nro 5, s. 962–965. doi:10.1093/schbul/sbt034 ISSN 0586-7614 Artikkelin verkkoversio.
J. Moilanen & M. Haapea & J. Miettunen & E. Jääskeläinen & J. Veijola & M. Isohanni: Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication - a 10-year follow-up of the Northern Finland 1966 Birth Cohort study. European Psychiatry: The Journal of the Association of European Psychiatrists, tammikuu 2013, nro 1, s. 53–58. doi:10.1016/j.eurpsy.2011.06.009 ISSN 1778-3585 Artikkelin verkkoversio.
Wils, Regitze Sølling & Gotfredsen, Ditte Resendal & Hjorthøj, Carsten & Austin, Stephen F. & Albert, Nikolai & Secher, Rikke Gry: Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis. Schizophrenia Research, huhtikuu 2017, nro 182, s. 42–48. doi:10.1016/j.schres.2016.10.030 ISSN 1573-2509 Artikkelin verkkoversio.
Harrow, Martin & Jobe, Thomas H.: Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multifollow-up study. The Journal of Nervous and Mental Disease, toukokuu 2007, nro 5, s. 406–414. doi:10.1097/01.nmd.0000253783.32338.6e ISSN 0022-3018 Artikkelin verkkoversio.
Wunderink, Lex & Nieboer, Roeline M. & Wiersma, Durk & Sytema, Sjoerd & Nienhuis, Fokko J.: Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial. JAMA psychiatry, syyskuu 2013, nro 9, s. 913–920. doi:10.1001/jamapsychiatry.2013.19 ISSN 2168-6238 Artikkelin verkkoversio.
Seeman, Philip & Weinshenker, David & Quirion, Remi & Srivastava, Lalit K. & Bhardwaj, Sanjeev K. & Grandy, David K.: Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis. Proceedings of the National Academy of Sciences of the United States of America, 1.3.2005, nro 9, s. 3513–3518. doi:10.1073/pnas.0409766102 ISSN 0027-8424 Artikkelin verkkoversio.
Dorph-Petersen, Karl-Anton & Pierri, Joseph N. & Perel, James M. & Sun, Zhuoxin & Sampson, Allan R. & Lewis, David A.: The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, syyskuu 2005, nro 9, s. 1649–1661. doi:10.1038/sj.npp.1300710 ISSN 0893-133X Artikkelin verkkoversio.
Ho, Beng-Choon & Andreasen, Nancy C. & Nopoulos, Peg & Arndt, Stephan & Magnotta, Vincent & Flaum, Michael: Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Archives of General Psychiatry, kesäkuu 2003, nro 6, s. 585–594. doi:10.1001/archpsyc.60.6.585 ISSN 0003-990X Artikkelin verkkoversio.
Ho, Beng-Choon & Andreasen, Nancy C. & Ziebell, Steven & Pierson, Ronald & Magnotta, Vincent: Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Archives of General Psychiatry, helmikuu 2011, nro 2, s. 128–137. doi:10.1001/archgenpsychiatry.2010.199 ISSN 1538-3636 Artikkelin verkkoversio.

pubmed.ncbi.nlm.nih.gov

Jari Tiihonen, Jari Haukka, Mark Taylor, Peter M. Haddad, Maxine X. Patel, Pasi Korhonen: A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. The American Journal of Psychiatry, June 2011, nro 6, s. 603–609. PubMed:21362741 doi:10.1176/appi.ajp.2011.10081224 ISSN 1535-7228 Artikkelin verkkoversio.
Peter Lepping, Rajvinder Singh Sambhi, Richard Whittington, Steven Lane, Rob Poole: Clinical relevance of findings in trials of antipsychotics: systematic review. The British Journal of Psychiatry: The Journal of Mental Science, 2011-05, nro 5, s. 341–345. PubMed:21525517 doi:10.1192/bjp.bp.109.075366 ISSN 1472-1465 Artikkelin verkkoversio.
Ni A. Khin, Yeh-Fong Chen, Yang Yang, Peiling Yang, Thomas P. Laughren: Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration. The Journal of Clinical Psychiatry, 2012-06, nro 6, s. 856–864. PubMed:22687813 doi:10.4088/JCP.11r07539 ISSN 1555-2101 Artikkelin verkkoversio.
Alexander M. Récalt, David Cohen: Withdrawal Confounding in Randomized Controlled Trials of Antipsychotic, Antidepressant, and Stimulant Drugs, 2000-2017. Psychotherapy and Psychosomatics, 2019, nro 2, s. 105–113. PubMed:30893683 doi:10.1159/000496734 ISSN 1423-0348 Artikkelin verkkoversio.
Stefan Leucht, Magdolna Tardy, Katja Komossa, Stephan Heres, Werner Kissling, Georgia Salanti: Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. The Lancet, 2.6.2012, nro 9831, s. 2063–2071. PubMed:22560607 doi:10.1016/S0140-6736(12)60239-6 ISSN 0140-6736 Artikkelin verkkoversio. (englanti)
P.B. Danborg, P.C. Gøtzsche: Benefits and harms of antipsychotic drugs in drug-naïve patients with psychosis: A systematic review. The International Journal of Risk & Safety in Medicine, Määritä ajankohta! PubMed:31561392 doi:10.3233/JRS-195063 ISSN 0924-6479 Artikkelin verkkoversio.
Martin Harrow, Thomas H. Jobe, Liping Tong: Twenty-year effects of antipsychotics in schizophrenia and affective psychotic disorders. Psychological Medicine, 8.2.2021, s. 1–11. PubMed:33550993 doi:10.1017/S0033291720004778 ISSN 1469-8978 Artikkelin verkkoversio.
J. Moilanen, M. Haapea, J. Miettunen, E. Jääskeläinen, J. Veijola, M. Isohanni: Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication - a 10-year follow-up of the Northern Finland 1966 Birth Cohort study. European Psychiatry: The Journal of the Association of European Psychiatrists, 2013-01, nro 1, s. 53–58. PubMed:21920710 doi:10.1016/j.eurpsy.2011.06.009 ISSN 1778-3585 Artikkelin verkkoversio.
Roman Kotov, Laura Fochtmann, Kaiqiao Li, Marsha Tanenberg-Karant, Eduardo A. Constantino, Joan Rubinstein: Declining Clinical Course of Psychotic Disorders Over the Two Decades Following First Hospitalization: Evidence From the Suffolk County Mental Health Project. The American Journal of Psychiatry, 11 01, 2017, nro 11, s. 1064–1074. PubMed:28774193 doi:10.1176/appi.ajp.2017.16101191 ISSN 1535-7228 Artikkelin verkkoversio.
Anastasia Levinta, Ilya Mukovozov, Christopher Tsoutsoulas: Use of a Gluten-Free Diet in Schizophrenia: A Systematic Review. Advances in Nutrition (Bethesda, Md.), 11 01, 2018, nro 6, s. 824–832. PubMed:30325398 doi:10.1093/advances/nmy056 ISSN 2156-5376 Artikkelin verkkoversio.

nimh.nih.gov

Schizophrenia National Institute of Mental Health. Viitattu 29.03.2018.

oulu.fi

Väitöstilaisuus Oulun yliopistossa. Lääketieteen lisensiaatti Jani Moilanen. Väitöstilaisuus 27.5.2016. http://www.oulu.fi/yliopisto/node/38221

oup.com

academic.oup.com

Tomi Bergström, Jyri J. Taskila, Birgitta Alakare, Päivi Köngäs-Saviaro, Jouko Miettunen, Jaakko Seikkula: Five-Year Cumulative Exposure to Antipsychotic Medication After First-Episode Psychosis and its Association With 19-Year Outcomes. Schizophrenia Bulletin Open, 1.1.2020, nro 1. doi:10.1093/schizbullopen/sgaa050 Artikkelin verkkoversio. (englanniksi)

psu.edu

citeseerx.ist.psu.edu

Genetic Hypothesis of Idiopathic Schizophrenia: Its Exorphin Connection. F. Curtis Dohan. https://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=3644139b78f680e65dc48a33cf2ea6b45cdbd0d6

psychiatryonline.org

ajp.psychiatryonline.org

Stefan Leucht, Claudia Leucht, Maximilian Huhn, Anna Chaimani, Dimitris Mavridis, Bartosz Helfer: Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors. American Journal of Psychiatry, 25.5.2017, nro 10, s. 927–942. doi:10.1176/appi.ajp.2017.16121358 ISSN 0002-953X Artikkelin verkkoversio.

schres-journal.com

Anja P. Husa & Irina Rannikko & Jani Moilanen & Marianne Haapea & Graham K. Murray & Jennifer Barnett: Lifetime use of antipsychotic medication and its relation to change of verbal learning and memory in midlife schizophrenia — An observational 9-year follow-up study. Schizophrenia Research, 1.9.2014, nro 1, s. 134–141. doi:10.1016/j.schres.2014.06.035 ISSN 0920-9964 (englanniksi) Artikkelin verkkoversio.

sitruunakustannus.fi

Tappava psykiatria ja lääkinnän harha Sitruuna Kustannus. Arkistoitu 22.12.2017. Viitattu 21.12.2017.

skitsofreniainfo.fi

Skitsofrenian merkit nähtävissä jo varhain - avun saaminen voi olla vaikeaa Skitsofreniainfo. Arkistoitu 27.7.2018. Viitattu 29.03.2018.

terve.fi

Skitsofrenian glutamaattihypoteesi Terve.fi. Viitattu 14.3.2016.

thelancet.com

Stefan Leucht, Magdolna Tardy, Katja Komossa, Stephan Heres, Werner Kissling, Georgia Salanti: Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. The Lancet, 2.6.2012, nro 9831, s. 2063–2071. PubMed:22560607 doi:10.1016/S0140-6736(12)60239-6 ISSN 0140-6736 Artikkelin verkkoversio. (englanti)

theseus.fi

Kukkohovi, Jukka: Lääkkeettömät hoitomuodot Harjamäen sairaalassa vuosina 1926-1952 – Internet-sivut Harjamäen sairaalamuseon käyttöön Kajaanin ammattikorkeakoulu - Opinnäytetyö. Kukkohovi. Viitattu 29.03.2018.

web.archive.org

Skitsofrenian merkit nähtävissä jo varhain - avun saaminen voi olla vaikeaa Skitsofreniainfo. Arkistoitu 27.7.2018. Viitattu 29.03.2018.
http://www.e-mielenterveys.fi/mielenterveyden-hairiot/psykoosi/ (Arkistoitu – Internet Archive)
Ville Nissinen ja Antti Pikkarainen: Neuroleptit psykoosilääkkeinä. (Arkistoitu – Internet Archive) Kajaanin ammattikorkeakoulu.
Tutkimus: Harhaäänet ovat länsimaissa ilkeämpiä kuin Intiassa ja Afrikassa HS.fi. Arkistoitu 13.3.2016. Viitattu 13.3.2016.
Tappava psykiatria ja lääkinnän harha Sitruuna Kustannus. Arkistoitu 22.12.2017. Viitattu 21.12.2017.

worldcat.org

Jari Tiihonen, Jari Haukka, Mark Taylor, Peter M. Haddad, Maxine X. Patel, Pasi Korhonen: A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. The American Journal of Psychiatry, June 2011, nro 6, s. 603–609. PubMed:21362741 doi:10.1176/appi.ajp.2011.10081224 ISSN 1535-7228 Artikkelin verkkoversio.
Peter Lepping, Rajvinder Singh Sambhi, Richard Whittington, Steven Lane, Rob Poole: Clinical relevance of findings in trials of antipsychotics: systematic review. The British Journal of Psychiatry: The Journal of Mental Science, 2011-05, nro 5, s. 341–345. PubMed:21525517 doi:10.1192/bjp.bp.109.075366 ISSN 1472-1465 Artikkelin verkkoversio.
Stefan Leucht, Claudia Leucht, Maximilian Huhn, Anna Chaimani, Dimitris Mavridis, Bartosz Helfer: Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors. American Journal of Psychiatry, 25.5.2017, nro 10, s. 927–942. doi:10.1176/appi.ajp.2017.16121358 ISSN 0002-953X Artikkelin verkkoversio.
Ni A. Khin, Yeh-Fong Chen, Yang Yang, Peiling Yang, Thomas P. Laughren: Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration. The Journal of Clinical Psychiatry, 2012-06, nro 6, s. 856–864. PubMed:22687813 doi:10.4088/JCP.11r07539 ISSN 1555-2101 Artikkelin verkkoversio.
Alexander M. Récalt, David Cohen: Withdrawal Confounding in Randomized Controlled Trials of Antipsychotic, Antidepressant, and Stimulant Drugs, 2000-2017. Psychotherapy and Psychosomatics, 2019, nro 2, s. 105–113. PubMed:30893683 doi:10.1159/000496734 ISSN 1423-0348 Artikkelin verkkoversio.
Stefan Leucht, Magdolna Tardy, Katja Komossa, Stephan Heres, Werner Kissling, Georgia Salanti: Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. The Lancet, 2.6.2012, nro 9831, s. 2063–2071. PubMed:22560607 doi:10.1016/S0140-6736(12)60239-6 ISSN 0140-6736 Artikkelin verkkoversio. (englanti)
P.B. Danborg, P.C. Gøtzsche: Benefits and harms of antipsychotic drugs in drug-naïve patients with psychosis: A systematic review. The International Journal of Risk & Safety in Medicine, Määritä ajankohta! PubMed:31561392 doi:10.3233/JRS-195063 ISSN 0924-6479 Artikkelin verkkoversio.
Martin Harrow, Thomas H. Jobe, Liping Tong: Twenty-year effects of antipsychotics in schizophrenia and affective psychotic disorders. Psychological Medicine, 8.2.2021, s. 1–11. PubMed:33550993 doi:10.1017/S0033291720004778 ISSN 1469-8978 Artikkelin verkkoversio.
J. Moilanen, M. Haapea, J. Miettunen, E. Jääskeläinen, J. Veijola, M. Isohanni: Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication - a 10-year follow-up of the Northern Finland 1966 Birth Cohort study. European Psychiatry: The Journal of the Association of European Psychiatrists, 2013-01, nro 1, s. 53–58. PubMed:21920710 doi:10.1016/j.eurpsy.2011.06.009 ISSN 1778-3585 Artikkelin verkkoversio.
Roman Kotov, Laura Fochtmann, Kaiqiao Li, Marsha Tanenberg-Karant, Eduardo A. Constantino, Joan Rubinstein: Declining Clinical Course of Psychotic Disorders Over the Two Decades Following First Hospitalization: Evidence From the Suffolk County Mental Health Project. The American Journal of Psychiatry, 11 01, 2017, nro 11, s. 1064–1074. PubMed:28774193 doi:10.1176/appi.ajp.2017.16101191 ISSN 1535-7228 Artikkelin verkkoversio.
Anastasia Levinta, Ilya Mukovozov, Christopher Tsoutsoulas: Use of a Gluten-Free Diet in Schizophrenia: A Systematic Review. Advances in Nutrition (Bethesda, Md.), 11 01, 2018, nro 6, s. 824–832. PubMed:30325398 doi:10.1093/advances/nmy056 ISSN 2156-5376 Artikkelin verkkoversio.
Martin Harrow, Thomas H. Jobe: Does Long-Term Treatment of Schizophrenia With Antipsychotic Medications Facilitate Recovery? Schizophrenia Bulletin, syyskuu 2013, nro 5, s. 962–965. doi:10.1093/schbul/sbt034 ISSN 0586-7614 Artikkelin verkkoversio.
J. Moilanen & M. Haapea & J. Miettunen & E. Jääskeläinen & J. Veijola & M. Isohanni: Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication - a 10-year follow-up of the Northern Finland 1966 Birth Cohort study. European Psychiatry: The Journal of the Association of European Psychiatrists, tammikuu 2013, nro 1, s. 53–58. doi:10.1016/j.eurpsy.2011.06.009 ISSN 1778-3585 Artikkelin verkkoversio.
Wils, Regitze Sølling & Gotfredsen, Ditte Resendal & Hjorthøj, Carsten & Austin, Stephen F. & Albert, Nikolai & Secher, Rikke Gry: Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis. Schizophrenia Research, huhtikuu 2017, nro 182, s. 42–48. doi:10.1016/j.schres.2016.10.030 ISSN 1573-2509 Artikkelin verkkoversio.
Harrow, Martin & Jobe, Thomas H.: Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multifollow-up study. The Journal of Nervous and Mental Disease, toukokuu 2007, nro 5, s. 406–414. doi:10.1097/01.nmd.0000253783.32338.6e ISSN 0022-3018 Artikkelin verkkoversio.
Wunderink, Lex & Nieboer, Roeline M. & Wiersma, Durk & Sytema, Sjoerd & Nienhuis, Fokko J.: Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial. JAMA psychiatry, syyskuu 2013, nro 9, s. 913–920. doi:10.1001/jamapsychiatry.2013.19 ISSN 2168-6238 Artikkelin verkkoversio.
Seeman, Philip & Weinshenker, David & Quirion, Remi & Srivastava, Lalit K. & Bhardwaj, Sanjeev K. & Grandy, David K.: Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis. Proceedings of the National Academy of Sciences of the United States of America, 1.3.2005, nro 9, s. 3513–3518. doi:10.1073/pnas.0409766102 ISSN 0027-8424 Artikkelin verkkoversio.
Samaha, Anne-Noël & Seeman, Philip & Stewart, Jane & Rajabi, Heshmat & Kapur, Shitij: “Breakthrough” Dopamine Supersensitivity during Ongoing Antipsychotic Treatment Leads to Treatment Failure over Time. Journal of Neuroscience, 14.3.2007, nro 11, s. 2979–2986. doi:10.1523/JNEUROSCI.5416-06.2007 ISSN 0270-6474 (englanniksi) Artikkelin verkkoversio.
Dorph-Petersen, Karl-Anton & Pierri, Joseph N. & Perel, James M. & Sun, Zhuoxin & Sampson, Allan R. & Lewis, David A.: The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, syyskuu 2005, nro 9, s. 1649–1661. doi:10.1038/sj.npp.1300710 ISSN 0893-133X Artikkelin verkkoversio.
Anja P. Husa & Irina Rannikko & Jani Moilanen & Marianne Haapea & Graham K. Murray & Jennifer Barnett: Lifetime use of antipsychotic medication and its relation to change of verbal learning and memory in midlife schizophrenia — An observational 9-year follow-up study. Schizophrenia Research, 1.9.2014, nro 1, s. 134–141. doi:10.1016/j.schres.2014.06.035 ISSN 0920-9964 (englanniksi) Artikkelin verkkoversio.
Ho, Beng-Choon & Andreasen, Nancy C. & Nopoulos, Peg & Arndt, Stephan & Magnotta, Vincent & Flaum, Michael: Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Archives of General Psychiatry, kesäkuu 2003, nro 6, s. 585–594. doi:10.1001/archpsyc.60.6.585 ISSN 0003-990X Artikkelin verkkoversio.
Ho, Beng-Choon & Andreasen, Nancy C. & Ziebell, Steven & Pierson, Ronald & Magnotta, Vincent: Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Archives of General Psychiatry, helmikuu 2011, nro 2, s. 128–137. doi:10.1001/archgenpsychiatry.2010.199 ISSN 1538-3636 Artikkelin verkkoversio.

yle.fi

Suomi - psykoosi- lääkityksen ddr! Yle. Viitattu 17.6.2016.
Kaiken takana onkin trauma? yle.fi. Viitattu 2.3.2016.